Fang Xie

Fang Xie has over 25 years of work experience in the pharmaceutical and biopharmaceutical industry. Their most recent role was as the Vice President Head of Biometrics at Upstream Bio starting in February 2023. Prior to that, they worked as the Vice President, Biometrics at Insmed Incorporated from November 2018 to November 2022. They also held positions such as Head of Biostatistics and Programming at CSL Behring from January 2014 to November 2018, Senior Director at Teva Pharmaceuticals from October 2011 to November 2013, Senior Director Biostatistics at Cephalon from December 2004 to October 2011, and Associate Director Biostatistics at Amgen from April 2004 to November 2004. They have also gained experience at other companies including Pfizer, Aventis Behring, GSK Vaccines, and Wyeth Lederle Vaccines.

Fang Xie holds a Bachelor's degree from Peking University. They also pursued a PhD in Biostatistics from Columbia University. However, specific start and end years for their education are not provided.